When looking for a partner to be a reliable extension of your pharmacy operation, it’s critical to select one that is accountable to you and raises the bar for quality and FDA compliance. Learn why and how QuVa is built to lead the future of 503B sterile compounding.
Providing the highest quality, ready-to-administer products, transparent and proactive customer service, process improvement consulting services, and new product development through our proven innovation engine are the core services QuVa provides to meet your clinical and patient care needs.
The Science of Sterile Compounding: to ensure the highest level of patient safety, now is more critical than ever to fall in line with requirements and optimize methods given changing and more strict rules and regulations.
The US Office of Inspector General (OIG) issued a report showing Only 2% of hospitals are considering building their own 503B operation, given equipment, facility design, and “huge leap in cost and talent” are major limitations.
Hospital C-suite and pharmacy executives are attuned to and worried about some similar issues like “governmental mandates” (e.g., State and Federal requirements), personnel shortages, patient safety, drug shortages.